USA 1-800-227-2862 (BBRAUN2)

Home > Products > OnGuard® Closed System Transfer Device (CSTD) > OnGuard Vial Adaptor for 20 mm and 13 mm Vials

OnGuard Vial Adaptor for 20 mm and 13 mm Vials

For closed reconstitution and withdrawal of medications with most 20 mm and 13 mm vials (with vial converter ring provided)

Description

Benefits of OnGuard® CSDT:

  • Majorityof hazardous drug compounding can be done with just 3 SKU. Designed to reduce waste, help make implementations easier and reduce confusion.
  • Just compound and go. No need to pre-prime or pre-activate the vial adaptor.
  • Click to lock. No push and twist. Linear connection designed to help reduce repetitive strain injury (RSI) and provide audible click for validation.
  • Flat and smooth valve surfaces. Designed for easier swabability and disinfection.
  • No proprietary components. Works with any off the shelf syringe, no need to stock new syringes.
  • 16G fluid pathway. Helps facilitate easier withdrawal of viscous fluids.
Product Identification
Product ID (Product Code)412111
Reference Number412111
NDC / WSN Number08021-4121-11
Latex Information Not made with Natural Rubber Latex
Storage and Shipping
Maximum Shelf Life (months)036
Ordering UnitCase
Units per Case200
Products Dimensions per Case15.250 x 11.750 x 11.250 inches
Product Shipping Weight per Case8.417 lb
  • URL
    NIOSH DRAFT Universal Protocol
  • URL
    NIOSH Recognition of CSTD Air-Cleaning Technology
  • URL
    ONS Webinar: Empowering Nurses. Improving Safety.
  • URL
    FDA ONB Clearance
  • PDF [320 KB]
    Prevention of Hazardous Drug Vapor Release by the Tevadaptor Vial Adaptor
  • PDF [848 KB]
    Head-to-Head Evaluation of CSTDs in a Health-System Oncology Clinic
  • PDF [1538 KB]
    A Universal Test Protocol for Assessment of all CSTD Technologies: Assessment of the Containment Performance of CSTDs that Either Employ a Mechanically Closed Physical Barrier or air Filtration Technology
  • PDF [3622 KB]
    Cytotoxic Exposure: Healthcare Worker Risks
  • PDF [241 KB]
    Evaluation of a Closed-System Cytotoxic Transfer Device in a Pharmaceutical Isolator